Registration

Please review the information below in order to register your laboratory’s participation in the GSK Blujepa (gepotidacin) AVEP.
Contact IHMA, Inc. with any questions about this process.

You will only be able to create one GSK Blujepa (gepotidacin) AVEP account per institution.


Introduction

The GSK Blujepa (gepotidacin) Antimicrobial Voluntary Evaluation Program (AVEP) provides Research Use Only (RUO) Blujepa (gepotidacin) gradient diffusion MIC strips and disks for non-diagnostic, in vitro antimicrobial susceptibility testing.

The purpose of this program is to provide laboratories with RUO antimicrobial susceptibility testing (AST) devices to aid in understanding the Blujepa (gepotidacin) susceptibility profile of pathogens in their laboratory before Blujepa (gepotidacin) specific AST devices are commercially available (In vitro diagnostic use; IVD).


AVEP Program Terms & Conditions

All testing materials are for in vitro evaluation use only. Use of any testing materials to determine therapeutic options for patient treatment or any other diagnostic purpose is prohibited. The User (user of the RUO AST devices) is prohibited from charging any patient or third-party payer for any testing materials or including the value of the testing materials on any cost report submitted to any government agency, patients or other third party. The User may not transfer any materials provided through this program, including Blujepa (gepotidacin) gradient diffusion strips and/or Blujepa (gepotidacin) disks, to another party or laboratory. The User acknowledges that the provision of testing materials through this program are not contingent on, nor intended to serve as an inducement or reward for, any past or future purchases of GSK products. In furtherance of the scientific objectives of this program, it is requested that the User submit their testing results to IHMA to permit further analysis related to laboratory susceptibility. GSK reserves the right to disclose any transfer of value provided in connection with this program in accordance with state and federal transparency laws. This program may be discontinued at any time.
The User shall comply with all then applicable laws, regulations, and rules promulgated to law including but not limited to, the federal Anti-Kickback statute, 42 U.S.C. § 1320a-7b(b) and similar State laws; Federal Food, Drug and Cosmetic Act and relevant regulations; the Food and Drug Administration’s Guidance on Industry-Supported Scientific and Educational Activities (1997); and American Medical Association ethics rules and opinions, if applicable. Further, User shall comply with the Investigational Review Boards (IRB), Good Clinical Practices (“GCP”), and Good Laboratory Practices (“GLC”).


Enrollment

Please read the following enrollment information carefully.


Please complete the following form to enroll in this program and receive a limited supply of Blujepa (gepotidacin) RUO AST testing devices. Upon registration request, IHMA, Inc. will complete your enrollment within 48 hours. By participating in the AVEP and accepting RUO testing materials, you agree to the Terms and Conditions listed above.

If you would like more information about this program or help with enrollment, please contact IHMA, Inc. (1-800-738-3344 or email gepotidacinavep@ihma.com).

Should you have any technical questions regarding the susceptibility testing of Blujepa (gepotidacin) or using these RUO products, please contact IHMA, Inc. at 1-800-738-3344 or email gepotidacinavep@ihma.com


Testing Material Selection

Please select the testing materials you wish to receive.


From the list below, please select preferred manufacturer's RUO Blujepa (gepotidacin) gradient diffusion strips or disks.
RUO Blujepa (gepotidacin) gradient diffusion strips:
RUO Blujepa (gepotidacin) disks:

Please confirm if this is for Routine AST, if not, please provide explanation below?


User Information

Please accurately provide the following information to ensure proper receipt of materials.




My GSK Blujepa (gepotidacin) AVEP Account Creation Details

Please provide your email, a password, and complete the reCAPTCHA™ challenge.